Want to see JP:6523 full AI Analyst Report?
6523 Stock Chart & Stats
¥1112.00
¥4.00(0.41%)
At close: 4:00 PM EST
¥1112.00
¥4.00(0.41%)
Day’s Range― - ―
52-Week Range¥920.00 - ¥1,189.00
Previous CloseN/A
Volume174.10K
Average Volume (3M)164.09K
Market Cap
¥140.05B
Enterprise Value¥348.64K
Total Cash (Recent Filing)¥39.82B
Total Debt (Recent Filing)¥234.56B
Price to Earnings (P/E)285.7
Beta0.48
Next Earnings
Aug 06, 2026EPS Estimate
21.97Next Dividend Ex-DateN/A
Dividend Yield3.82%
Share Statistics
EPS (TTM)3.85
Shares Outstanding127,320,915
10 Day Avg. Volume194,380
30 Day Avg. Volume164,093
Financial Highlights & Ratios
PEG Ratio-2.94
Price to Book (P/B)0.85
Price to Sales (P/S)0.38
P/FCF Ratio4.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)129.32
Revenue Forecast (FY)¥366.66B
Bulls Say, Bears Say
Bulls Say
Recurring Consumables & Diversified ModelPHC's product mix ties capital equipment sales to ongoing consumable and service demand across diagnostics, life sciences, and medical devices. That installed-base recurring revenue reduces revenue cyclicality, supports predictable cash flow, and enhances long-term customer lock-in across markets.
Consistent Positive Free Cash FlowOperating and free cash flow resilience—even through prior loss years—gives PHC flexibility to fund working capital, service debt, and selectively invest in R&D or tuck-ins. Reliable cash conversion underpins balance sheet repair and reduces refinancing risk over the medium term.
Stable Gross Margins And Improving RevenueMid‑40% gross margins indicate durable product pricing and mix advantages in diagnostics and lab equipment. Coupled with recent revenue acceleration, this suggests the company can sustain scale economics and support margin recovery if operating costs are controlled.
Bears Say
Volatile ProfitabilityLarge swings from multi-year losses to a one-year profit then back to near break‑even indicate earnings are not yet stable. This volatility undermines planning, makes capital allocation harder, and raises execution risk for sustaining profit improvement over the next several quarters.
Elevated Leverage Despite ImprovementAlthough leverage has improved materially, debt remains sizable relative to equity. Persistent leverage constrains financial flexibility, increases interest and refinancing exposure, and limits the firm's capacity to fund growth or weather industry shocks without further deleveraging.
Operating Cash Flow Covers Modest Share Of DebtPositive OCF is a strength, but coverage of total debt at only low‑to‑mid 20% implies limited headroom. The company remains reliant on sustained cash generation or refinancing to reduce leverage, so any earnings or cash setbacks could pressure liquidity and balance‑sheet repair timelines.
PHC Holdings Corp. News
6523 FAQ
What was PHC Holdings Corp.’s price range in the past 12 months?
PHC Holdings Corp. lowest stock price was ¥920.00 and its highest was ¥1189.00 in the past 12 months.
What is PHC Holdings Corp.’s market cap?
PHC Holdings Corp.’s market cap is ¥140.05B.
When is PHC Holdings Corp.’s upcoming earnings report date?
PHC Holdings Corp.’s upcoming earnings report date is Aug 06, 2026 which is in 3 days.
How were PHC Holdings Corp.’s earnings last quarter?
PHC Holdings Corp. released its earnings results on May 13, 2026. The company reported -¥1.6 earnings per share for the quarter, missing the consensus estimate of ¥15.83 by -¥17.43.
Is PHC Holdings Corp. overvalued?
According to Wall Street analysts PHC Holdings Corp.’s price is currently Overvalued.
Does PHC Holdings Corp. pay dividends?
PHC Holdings Corp. pays a Semiannually dividend of ¥21 which represents an annual dividend yield of 3.82%. See more information on PHC Holdings Corp. dividends here
What is PHC Holdings Corp.’s EPS estimate?
PHC Holdings Corp.’s EPS estimate is 21.97.
How many shares outstanding does PHC Holdings Corp. have?
PHC Holdings Corp. has 127,320,915 shares outstanding.
What happened to PHC Holdings Corp.’s price movement after its last earnings report?
PHC Holdings Corp. reported an EPS of -¥1.6 in its last earnings report, missing expectations of ¥15.83. Following the earnings report the stock price went down -1.957%.
Which hedge fund is a major shareholder of PHC Holdings Corp.?
Currently, no hedge funds are holding shares in JP:6523
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PHC Holdings Corp.
PHC Holdings Corporation, through its network of subsidiaries, specializes in the innovation, production, and sale of medical instruments, advanced healthcare technology solutions, and life science merchandise. The company's product line includes blood glucose monitoring systems and a variety of other diagnostic and analytical tools, alongside sophisticated data integration platforms. It also delivers end-to-end anatomical pathology solutions, featuring specialized equipment, microscope slides, and diverse staining reagents. In the life sciences sector, PHC provides essential equipment and support services for sample preservation and cell culture. Furthermore, the company develops and deploys healthcare IT products, focusing on medical information systems designed for clinics and pharmacies dealing with health insurance. Its operations also extend to clinical testing, the manufacturing of diagnostic reagents, and providing support for pharmaceutical development. Established in 2014 and based in Tokyo, Japan, the company was formerly recognized as Panasonic Healthcare Holdings Co., Ltd. before officially changing its name to PHC Holdings Corporation in April 2018.
Technical Analysis
Eiken Chemical Co., Ltd.
―
Techno Medica Co., Ltd.
―
Nihon Kohden Corporation
―
Japan Medical Dynamic Marketing, Inc.
―
Koken Ltd.
―